Wuhan Hiteck Biological Pharma Co Ltd

300683

Company Profile

  • Business description

    Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.

  • Contact

    Hite Science and Technology Park
    Wuhan Economic and Technological Development Zone
    Hubei Province
    Wuhan430056
    CHN

    T: +86 2784599931

    http://www.hiteck.com.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,309

Stocks News & Analysis

stocks

The ASX player evolving into a defensive haven

A well-timed simplification journey as boring evolves back in vogue.
stocks

12 picks for an income portfolio - Q1 2026 update

Passive income growth continues to exceed my target.
stocks

Strong guidance from undervalued ASX share

Shares surged after the announcement of first half fiscal 2026 guidance.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,174.1012.000.13%
CAC 408,331.0594.08-1.12%
DAX 4024,417.80284.44-1.15%
Dow JONES (US)49,373.9973.44-0.15%
FTSE 10010,609.0858.55-0.55%
HKSE26,361.07200.740.77%
NASDAQ24,340.97127.51-0.52%
Nikkei 22558,824.89348.990.60%
NZX 50 Index12,915.459.780.08%
S&P 5007,100.6025.46-0.36%
S&P/ASX 2008,953.3013.600.15%
SSE Composite Index4,082.1330.700.76%

Market Movers